Analyte monitoring systems and methods

Abstract

An improved graphical user interface for an analyte monitoring system is provided. For example, various embodiments of GUIs are disclosed herein, each GUI comprising: a graphical portion comprising a trend line indicative of an analyte level of a user over a predetermined period of time; and a plurality of summary metrics including a plurality of minimum analyte levels and maximum analyte levels associated with the plurality of time increments within the predetermined time period. In many embodiments, the plurality of minimum analyte levels and the maximum analyte level are aligned with the x-axis of the graphical portion.

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to U.S. Provisional Application No. 63 / 538,592, filed on September 15, 2023, and U.S. Provisional Application No. 63 / 407,430, filed on September 16, 2022, both of which are expressly incorporated herein by reference in their entirety for all purposes. Technical Field

[0003] The subject matter described herein relates generally to improvements in analyte monitoring systems, and computer-related methods and apparatus related thereto. Background Art

[0004] Detecting and / or monitoring analyte levels (such as glucose, ketones, lactate, oxygen, hemoglobin A1C, etc.) can be critical to the health of a diabetic patient. A diabetic patient may experience complications, including loss of consciousness, cardiovascular disease, retinopathy, neuropathy, and nephropathy. It is often necessary to monitor the glucose levels of a diabetic patient to ensure that they remain within a clinically safe range, and this information can also be used to determine if and / or when insulin is needed to lower the glucose level in their body, or when additional glucose is needed to raise the glucose level in their body.

[0005] A growing body of clinical data demonstrates a strong correlation between glucose monitoring frequency and glucose control. However, despite this correlation, many people diagnosed with diabetes do not monitor their glucose levels as frequently as they should due to a combination of factors, including convenience, testing discretion, pain associated with glucose testing, and cost.

[0006] In order to increase the patient's compliance with the frequent glucose monitoring plan, an in vivo analyte monitoring system can be utilized, wherein the sensor control device can be worn on the body of the individual who needs analyte monitoring. In order to increase the comfort and convenience of the individual, the sensor control device can have a small form factor and can be applied by the individual with a sensor applicator. The application process includes inserting at least a portion of a sensor (sensing the user's analyte level in the body fluid of the human body layer) using an applicator or insertion mechanism so that the sensor is in contact with the body fluid. The sensor control device can also be configured to transmit analyte data to another device, and the individual or her health care provider ("HCP") or caregiver can review the data from the device and make treatment decisions.

[0007] However, despite the advantages of analyte monitoring systems, some people are reluctant to use analyte monitoring systems for a variety of reasons including the complexity and amount of data provided, the learning curve associated with software and user interfaces for analyte monitoring systems, and the overall lack of actionable information provided.

[0008]

[0006] Therefore, there is a need for improved reporting interfaces and software for analyte monitoring systems, and methods and apparatus related thereto, that are robust, user-friendly, and provide timely and actionable responses. Summary of the invention

[0009] Provided herein are exemplary embodiments of improvements to in vivo analyte monitoring systems and computer-related methods and devices associated therewith. According to some embodiments, a graphical user interface ("GUI") of an analyte monitoring system is provided, wherein the GUI includes a graphical portion including a trend line indicating the analyte level of a user within a predetermined time period, wherein the trend line is based on data indicating the analyte level of the user received from a sensor control device. In some embodiments, the graphical portion includes a graphical display of the analyte level of the user within a predetermined time period. The graphical portion may have an x-axis line representing a predetermined time period. For example, the graphical portion may include a plurality of data points representing the analyte level of the user within a predetermined time period (e.g., in the form of a scatter plot). In some examples, a plurality of data points may be linked together by a line (e.g., in the form of a line graph). In other examples, a plurality of data points may be discrete and not linked together by a line. According to one aspect of some embodiments, the GUI also includes a plurality of summary metrics associated with a predetermined time period. In some examples, the summary metrics are associated with the analyte level of the user. According to one aspect of some embodiments, a plurality of summary metrics include a plurality of minimum analyte levels and a maximum analyte level associated with a plurality of time increments within a predetermined time period. In other words, the plurality of summary metrics may include a minimum analyte level and a maximum analyte level for each of a plurality of time increments within a predetermined time period. In some embodiments, the predetermined time period is one day. For example, the plurality of time increments may include twenty-four (24) one-hour increments. In other words, for example, each time increment may have a duration of one hour. In some embodiments, the plurality of minimum analyte levels and the maximum analyte levels are aligned with the x-axis of the graphical portion. For example, each minimum analyte level and the maximum analyte level may be aligned with a corresponding time interval on the x-axis, and for different time intervals, the plurality of minimum analyte levels and the maximum analyte levels are displayed along the x-axis.

[0010] Many of the embodiments provided herein are improved reporting GUIs or GUI features for analyte monitoring systems that are highly intuitive, user-friendly, and provide quick access to a user's physiological information. More specifically, these embodiments allow a user to easily navigate between different user interfaces that can quickly indicate to the user various physiological conditions and / or actionable responses without requiring the user (or HCP) to complete the arduous task of reviewing large amounts of analyte data.

[0011] The various aspects described and claimed herein provide improvements to the GUI that produce a technical effect at least in helping the user of the device operate the device more accurately, more efficiently, and more safely. It will be appreciated that the information provided to the user via the reporting GUI, the order in which the information is provided, and the structural clarity of the information may have a significant impact on the way the user interacts with the system and the way the system operates. Thus, the reporting GUI guides the user to accurately and efficiently take necessary readings and / or obtain information in the technical tasks of operating the system. Other improvements and advantages are also provided. Various configurations of these devices are described in detail by way of exemplary embodiments only.

[0012] Other systems, devices, methods, features, and advantages of the subject matter described herein will be or will become apparent to those skilled in the art by examining the following figures and detailed description. All of these additional systems, devices, methods, features, and advantages are included in this specification, are within the scope of the subject matter described herein, and are protected by the appended claims. Aspects of the embodiments are set forth in the independent claims, and preferred features are set forth in the dependent claims. Preferred features of the dependent claims may be provided in combination in a single embodiment, and preferred features of one aspect may also be provided in combination with other aspects. Features of the exemplary embodiments should never be interpreted as limiting the appended claims without explicitly stating these features in the claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] The details of the subject matter described herein, both as to its structure and operation, may be apparent by studying the accompanying drawings, in which like reference numerals refer to like parts. The components in the figures are not necessarily drawn to scale, emphasis instead being placed on illustrating the principles of the subject matter. Furthermore, all illustrations are intended to convey concepts, in which relative size, shape, and other detailed attributes may be illustrated schematically rather than literally or precisely.

[0014] Figure 1 is a system overview of an analyte monitoring system including a sensor applicator, a sensor control device, a reader device, a network, a trusted computer system, and a local computer system.

[0015] Figure 2Ais a block diagram depicting an exemplary embodiment of a reader device.

[0016] Figure 2B and Figure 2C is a block diagram depicting an exemplary embodiment of a sensor control device.

[0017] FIG. 3A to FIG. 3L are exemplary embodiments of various graphical user interfaces ("GUIs") and reporting GUIs, each of which indicates a user's analyte level and a plurality of summary metrics during a predetermined time period.

[0018] Figure 4A is an exemplary embodiment of a report setup GUI for enabling and / or disabling the display of minimum and maximum analyte levels.

[0019] FIG. 4B to FIG. 4E are exemplary embodiments of GUIs and reporting GUIs in which the display of minimum and maximum analyte levels has been enabled or disabled.

[0020] Figure 5 is an exemplary embodiment of a reporting GUI that indicates analyte levels and summary metrics for a plurality of analytes during a plurality of predetermined time periods. DETAILED DESCRIPTION

[0021] Before describing the present subject matter in detail, it should be understood that the present disclosure is not limited to the particular embodiments described, as such may of course vary. It should also be understood that the terminology used herein is only for the purpose of describing particular embodiments and is not intended to be limiting, as the scope of the present disclosure will be limited only by the appended claims.

[0022] As used herein and in the appended claims, the singular forms "a," "an," and "the" include plural references unless the context clearly dictates otherwise.

[0023] The publications discussed herein are only used to be disclosed before the filing date of the present application. Nothing herein should be construed as admitting that the present disclosure is not entitled to be published in advance by virtue of a previous disclosure. In addition, the publication date provided may be different from the actual publication date, which may require independent confirmation.

[0024] In general, embodiments of the present disclosure include GUIs, software, and digital interfaces for analyte monitoring systems, and methods and apparatus related thereto. Thus, many embodiments include an in vivo analyte sensor that is structurally configured such that at least a portion of the sensor is or can be positioned in the body of a user to obtain information about at least one analyte of the body. However, it should be noted that the embodiments disclosed herein can be used with in vivo analyte monitoring systems that incorporate in vitro capabilities as well as purely in vitro or ex vivo analyte monitoring systems (including completely non-invasive systems).

[0025] In addition, for each embodiment of the method disclosed herein, systems and devices capable of performing each of these embodiments are included within the scope of the present disclosure. For example, embodiments of sensor control devices, reader devices, local computer systems, and trusted computer systems are disclosed, and these devices and systems can have one or more sensors, analyte monitoring circuits (e.g., analog circuits), memories (e.g., for storing instructions), power supplies, communication circuits, transmitters, receivers, processors, and / or controllers (e.g., for executing instructions), which can perform any and all method steps or facilitate the performance of any and all method steps.

[0026] Improved reporting graphical user interfaces for analyte monitoring systems are provided. For example, various embodiments of graphical user interfaces ("GUIs") are disclosed herein. The GUIs are highly intuitive, user-friendly, and provide quick access to a user's physiological information. In summary, these embodiments provide a powerful, user-friendly interface that can increase user engagement with an analyte monitoring system and provide a user with timely and actionable responses, to name a few advantages. Other improvements and advantages are also provided. Various configurations of these devices are described in detail by way of example only.

[0027] However, before describing these aspects of the embodiments in detail, it is first desirable to describe examples of devices that may be present, for example, within an in vivo analyte monitoring system, as well as examples of their operation, all of which may be used with the embodiments described herein.

[0028] There are various types of in vivo analyte monitoring systems. For example, a "continuous analyte monitoring" system (or "continuous glucose monitoring" system) can continuously transmit data from a sensor control device to a reader device without prompting (e.g., automatically according to a schedule). As another example, a "transient analyte monitoring" system (or "transient glucose monitoring" system or simply "transient" system) can respond to a scan or data request from a reader device, such as by near field communication (NFC) or radio frequency identification (RFID) protocol, to transmit data from a sensor control device. In vivo analyte monitoring systems can also operate without the need for fingertip calibration.

[0029] In vivo analyte monitoring systems can be distinguished from "in vitro" systems that contact a biological sample outside the body (or "ex vivo") and generally include a meter assembly having a port for receiving an analyte test strip carrying a user's bodily fluid, which can be analyzed to determine the user's blood glucose level.

[0030] The in-vivo monitoring system may include a sensor that, when positioned in the body, contacts the user's bodily fluids and senses the level of an analyte contained therein. The sensor may be part of a sensor control device located on the user's body and include electronics and a power source that enable and control analyte sensing. The sensor control device and its variants may also be referred to as a "sensor control unit," "on-body electronics" device or unit, "on-body" device or unit, or "sensor data communication" device or unit, to name a few.

[0031] The in vivo monitoring system may also include a device that receives sensed analyte data from the sensor control device and processes and / or displays the sensed analyte data to the user in any number of forms. The device and its variants may be referred to as a "handheld reader device," "reader device" (or simply "reader"), a "handheld electronic device" (or simply "handheld"), a "portable data processing" device or unit, a "data receiver," a "receiver" device or unit (or simply "receiver"), or a "remote" device or unit, to name a few. Other devices (such as personal computers) have also been used with or incorporated into in vivo and in vitro monitoring systems.

[0032] Exemplary Embodiments of In Vivo Analyte Monitoring Systems

[0033] Figure 11 is a conceptual diagram depicting an exemplary embodiment of an analyte monitoring system 100, which includes a sensor applicator 150, a sensor control device 102, and a reader device 120. Here, the sensor applicator 150 can be used to deliver the sensor control device 102 to a monitoring location on the user's skin, where the sensor 104 is held in place for a period of time by an adhesive patch 105. Figure 2B and Figure 2C 120 , and can communicate with the reader device 120 via a communication path 140 using wired or wireless technology. Exemplary wireless protocols include Bluetooth, Bluetooth Low Energy (BLE, BTLE, Bluetooth SMART, etc.), near field communication (NFC), etc. A user can view and use applications installed in a memory on the reader device 120 using a screen 122 (which may include a touch screen in many embodiments) and an input 121 (which may be part of a touch screen). The device battery of the reader device 120 can be recharged using a power port 123. Although only one reader device 120 is shown, the sensor control device 102 can communicate with multiple reader devices 120. Each reader device 120 can communicate and share data with each other. More details about the reader device 120 are described below in detail. Figure 2A . The reader device 120 can communicate with the local computer system 170 via the communication path 141 using a wired or wireless communication protocol. The local computer system 170 can include one or more of a laptop, desktop, tablet, flat-screen TV, smart phone, set-top box, video game console, or other computing device, and the wireless communication can include any of a plurality of applicable wireless networking protocols including Bluetooth, Bluetooth Low Energy (BTLE), Wi-Fi, or others. The local computer system 170 can communicate with the network 190 via the communication path 143, similar to the manner in which the reader device 120 can communicate with the network 190 via the communication path 142 as previously described by the wired or wireless communication protocol. The network 190 can be any of many networks such as private networks and public networks, local area networks, or wide area networks. The trusted computer system 180 can include a cloud-based platform or server, and can provide authentication services, secure data storage, report generation, and can communicate with the network 190 via the communication path 144 by wired or wireless technology. In addition, although Figure 1 The trusted computer system 180 and the local computer system 170 are depicted as communicating with a single sensor control device 102 and a single reader device 120, but those skilled in the art will appreciate that the local computer system 170 and / or the trusted computer system 180 are each capable of wired or wireless communication with multiple reader devices and sensor control devices.

[0034] Exemplary Embodiments of Reader Devices

[0035] Figure 2A 1 is a block diagram depicting an exemplary embodiment of a reader device 120, which in some embodiments may include a smart phone. Here, the reader device 120 may include a display 122, an input component 121, and a processing core 206, which includes a communication processor 222 coupled to a memory 223 and an application processor 224 coupled to a memory 225. A separate memory 230, an RF transceiver 228 with an antenna 229, and a power supply 226 with a power management module 238 may also be included. In addition, the reader device 120 may also include a multi-function transceiver 232, which may include wireless communication circuitry and may be configured to communicate with the antenna 234 via Wi-Fi, NFC, Bluetooth, BTLE, and GPS. As will be appreciated by those skilled in the art, these components are electrically coupled and communicatively coupled in a manner to form a functional device. The reader device 120 may be provided in conjunction with the sensor control device 102 to form an analyte monitoring system, or may be provided separately (e.g., for use with the sensor control device 102). The reader device 120 and / or the sensor control device 102 may be provided in conjunction with a sensor applicator 150 for delivering the sensor control device 102 to the user's skin. For example, the sensor applicator 150 may be used to insert a portion of the analyte sensor 104 into the user's skin.

[0036] Exemplary Embodiments of a Sensor Control Device

[0037] Figure 2B and Figure 2C 1 is a block diagram depicting an exemplary embodiment of a sensor control device 102 having an analyte sensor 104 and sensor electronics 160 (including analyte monitoring circuitry), which may have most of the processing capabilities for presenting final result data suitable for display to a user. The analyte sensor 104 may include a portion configured to be inserted into a user's body, such as a portion positioned to contact a bodily fluid (e.g., interstitial fluid). Figure 2B, a single semiconductor chip 161 is depicted, which may be a customized application-specific integrated circuit (ASIC). Shown within ASIC 161 are certain advanced functional units, including an analog front end (AFE) 162, a power management (or control) circuit 164, a processor 166, and a communication circuit 168 (which may be implemented as a transmitter, a receiver, a transceiver, a passive circuit, or otherwise implemented according to a communication protocol). In this embodiment, both AFE 162 and processor 166 are used as analyte monitoring circuits, but in other embodiments, either circuit may perform analyte monitoring functions. Processor 166 may include one or more processors, microprocessors, controllers, and / or microcontrollers, each of which may be a discrete chip or distributed between multiple different chips (and portions thereof).

[0038] Memory 163 is also included in ASIC 161 and can be shared by various functional units present in ASIC 161, or can be distributed between two or more functional units therein. Memory 163 can also be a separate chip. Memory 163 can be volatile and / or non-volatile memory. In this embodiment, ASIC 161 is coupled to power supply 172, which can be a coin cell battery, etc. AFE 162 interfaces with in vivo analyte sensor 104, receives measurement data therefrom, and outputs the data in digital form to processor 166, which in turn processes the data to derive final results such as glucose discrete data and trend values. The data can then be provided to communication circuit 168 for transmission to reader device 120 (not shown) via antenna 171, for example, in the data receiving device, the resident software application requires minimal further processing to display the data. According to some embodiments, for example, the current glucose value can be periodically (e.g., every minute) transmitted from sensor control device 102 to reader device 120. In some examples, historical glucose values ​​may be transmitted from the sensor control device 102 to the reader device 120 periodically (eg, every five minutes).

[0039] In some embodiments, to conserve power and processing resources on the sensor control device 102, the digital data received from the AFE 162 may be sent to the reader device 120 (not shown) with minimal or no processing. In still other embodiments, the processor 166 may be configured to generate certain predetermined data types (e.g., current glucose values, historical glucose values) for storage in the memory 163 or transmission to the reader device 120 (not shown), and to determine certain alarm conditions (e.g., sensor fault conditions), while other processing and alarm functions (e.g., high / low glucose threshold alarms) may be performed on the reader device 120. Those skilled in the art will appreciate that the methods, functions, and interfaces described herein may be performed in whole or in part by processing circuitry on the sensor control device 102, the reader device 120, the local computer system 170, or the trusted computer system 180.

[0040] Figure 2C Similar to Figure 2B , but instead includes two discrete semiconductor chips 162 and 174, which can be packaged together or separately. Here, AFE 162 resides on ASIC 161. Processor 166 is integrated with power management circuit 164 and communication circuit 168 on chip 174. AFE 162 may include memory 163 and chip 174 includes memory 165, which may be isolated or distributed therein. In one exemplary embodiment, AFE 162 is combined with power management circuit 164 and processor 166 on one chip, while communication circuit 168 is on a separate chip. In another exemplary embodiment, both AFE 162 and communication circuit 168 are on one chip, and processor 166 and power management circuit 164 are on another chip. It should be noted that other chip combinations are also possible, including three or more chips, each chip assuming responsibility for the individual functions described, or sharing one or more functions to achieve fail-safe redundancy.

[0041] Exemplary Embodiments of Graphical User Interfaces for Analyte Monitoring Systems

[0042] Exemplary embodiments of GUIs for analyte monitoring systems are described herein. First, those skilled in the art will appreciate that the GUIs described herein include instructions stored in a memory of a trusted computer system 180, a reader device 120, a local computer system 170, and / or any other device or system that is part of or communicates with the analyte monitoring system 100. These instructions, when executed by one or more processors of the trusted computer system 180, the reader device 120, the local computer system 170, or other devices or systems of the analyte monitoring system 100, cause the one or more processors to perform the method steps described herein and / or output a GUI. Those skilled in the art will further recognize that the GUIs described herein may be stored as instructions in the memory of a single centralized device, or, in another case, may be distributed across multiple discrete devices that are geographically dispersed.

[0043] Figure 3A An exemplary embodiment of a GUI 300 for an analyte monitoring system is depicted, wherein the GUI 300 depicts a user's analyte level over a predetermined time period in conjunction with multiple summary metrics. Generally, the GUI 300 can display a graph representing the user's analyte level over a predetermined time period in a single user-friendly format, along with multiple useful summary metrics based on or associated with analyte data obtained from the analyte monitoring system. In addition, the multiple summary metrics displayed in the GUI 300 can be associated with a predetermined time period (e.g., a day, a week, or a month). In other words, multiple summary metrics can be associated with analyte data from a predetermined time period. For example, as Figure 3A As shown in FIG. 3 , GUI 300 is configured to display a graph of a user's analyte levels and a plurality of summary metrics for a day, as indicated by date 302 (eg, “Sunday, June 3”).

[0044] According to one aspect of the embodiment, the GUI 300 may include a graphical portion including an x-axis 309 based on time units and a y-axis 307 indicating analyte concentrations. For example, the GUI 300 includes an x-axis 309 and a y-axis 307, the x-axis being labeled in two-hour increments over a twenty-four hour period, and the y-axis being labeled in milligrams of glucose per deciliter (mg / dL). It will be appreciated by those skilled in the art that the x-axis and / or y-axis may be labeled with other increments or units. For example, the x-axis may be labeled as thirty minute increments, one hour increments, or four hour increments, etc. As another example, the y-axis may be displayed in millimoles of glucose per liter (mmol / L).

[0045] According to another aspect of the embodiment, the graphical portion of the GUI 300 can also display a high analyte threshold ("180 mg / dL") and a low analyte threshold ("70 mg / dL") for the target analyte range 308, as shown in the digital labels on the left. In some embodiments, the numerical value for the target analyte range 308 can be a different color from the label on the x-axis and / or y-axis to make it more distinctive. In addition, in some embodiments, multiple lines (each line reflecting the corresponding threshold of the target analyte range 308) can extend through the graphical portion to provide a visual reference for the relationship between the user's analyte level and the target analyte range 308 at any point in time. For example, these lines can include a high analyte threshold line and a low analyte threshold line. In some examples, the line can be colored, such as where the line for each threshold is a different color. This allows the user to more easily compare their analyte level with the target analyte range 308 at a specific time point, thereby improving the safety of the patient. Additionally, according to some embodiments, the target analyte range 308 may be configurable by a user, for example, by adjusting either or both of the high analyte threshold or the low analyte threshold. In some embodiments, the threshold lines may be provided without numerical labels.

[0046] Still reference Figure 3A , the graphical portion of the GUI 300 may include a trend line 310 that displays the user's analyte concentration over a predetermined time period. According to one aspect of the embodiment, certain portions of the trend line 310 may be displayed in a first color (e.g., green) to indicate that at a specified time, the user's analyte level is within the target analyte range 308. Other portions 312 of the trend line may be displayed in a second color (e.g., orange) to indicate that at different indicated times, the user's analyte level is above the target analyte range 308. Similarly, other portions 318 of the trend line may be displayed in a third color (e.g., red) to indicate that at different indicated times, the user's analyte level is below the target analyte range 308. In some embodiments, if the user's analyte level is above or below the target analyte range, the corresponding area below (or above) the trend line may be shaded or filled (e.g., with a specific color). For example, if the user's analyte level is above the target analyte range, the corresponding area below (or above) the trend line may be shaded or filled with a second color, and / or if the user's analyte level is below the target analyte range, it may be shaded or filled with a third color. Figure 3AAs shown in , the colored regions can extend from the line indicating that the analyte threshold is exceeded to the trend line. In this regard, these colored regions can graphically represent to the user the severity and / or duration of the analyte excursion. In contrast, if the user remains within the target analyte range 308 during the predetermined time period, the trend line remains colored according to the first color (e.g., green).

[0047] According to some embodiments, the corresponding area below (or above) the trend line can remain colorless. In still other embodiments, the trend line can be a single color regardless of whether the analyte level is above, below, or within the target analyte range 308.

[0048] According to some embodiments, some information can also be superimposed on the graph near the trend line.For example, in some analyte monitoring systems, the analyte inspection 315 initiated by the user can be graphically represented as one or more discrete points on the graph to indicate the time when the inspection occurs. The analyte inspection initiated by the user can be, for example, a fingertip blood glucose test, a scan of a sensor control device, downloading analyte data from a trusted computer system, a view of an analyte monitoring program on a reader device and / or a presentation of a specific GUI (e.g., home screen, sensor result screen) of an analyte monitoring program on a reader device. Those skilled in the art will appreciate that other types of user-initiated analyte inspections are possible and within the scope of the present disclosure. According to another aspect of some embodiments, an exercise event can be graphically represented as an exercise icon 316 on a graph to indicate the time when the exercise event occurs. Information (e.g., corresponding to events such as analyte inspections 315 and exercise icons 316 initiated by a user) can be displayed on a graph or adjacent to a graph, such as aligned with the x-axis line.

[0049] According to another aspect of some embodiments, GUI 300 may include one or more summary metrics. For example, in some embodiments, GUI 300 may include a "time in range" metric 304 to indicate the percentage of time (e.g., "79%) that the user's analyte data is within the target analyte range within a predetermined time period. In other embodiments, the "time in range" metric 304 can be displayed as a graphical representation (e.g., a pie chart, multiple bar sections, partially filled rings), or in an alternative, as a digital time amount. Other types of graphical representations of "time in range" metrics are described in U.S. Publication Nos. 2021 / 0282673, 2022 / 0248988, 2021 / 037860, 2022 / 0000399, 2021 / 0030323, 2022 / 0092019, and 2022 / 0110551, all of which are incorporated by reference in their entirety for all purposes.

[0050] Still reference Figure 3A , the summary metric may also include the total amount of food or medicine 306 taken in during the predetermined time period. In some embodiments, for example, the summary metric may include the amount of carbohydrates taken in by the user during the predetermined time period (in grams), and / or the type (e.g., quick-acting or long-acting) and number of units of insulin injected by the user during the predetermined time period. The summary metric may include separate metrics for different types of insulin (e.g., quick-acting and long-acting), or these metrics may be combined. According to another aspect of the embodiment, specific food and / or drug events 314 may be displayed next to the graph (e.g., above the trend line, below the trend line) so that each food and / or drug event is aligned with the indicated time reflected along the x-axis. According to one aspect of some embodiments, each type of summary metric may be displayed in different colors associated with the associated events displayed in the graphic portion of the report GUI 300, as described below.

[0051] Next reference Figure 3B , depicts an exemplary embodiment of a report GUI 320 for an analyte monitoring system, wherein the report GUI 320 includes a plurality of interfaces 320-A, 320-B, 320-C, 320-D, and 320-E, wherein each interface depicts the user's analyte level over different predetermined time periods in combination with a plurality of summary metrics. First, each of the plurality of interfaces 320-A, 320-B, 320-C, and 320-E includes Figure 3A 320-A depicts a daily view of the user's analyte levels on Thursday, May 31, and a plurality of summary metrics for that particular date. Similarly, interface 320-B depicts a daily view of the user's analyte levels on Friday, June 1, and a plurality of summary metrics for that particular date. In other words, reporting GUI 320 includes daily views of the user's analyte levels for a plurality of predetermined time periods (e.g., a plurality of days). However, similar to Figure 3A Unlike the GUI 300 of the present invention, the interface of the report GUI 320 displays the labels for the y-axis and target analyte range along the right side of each graph rather than the left side. In other examples, the labels may be located on the left side.

[0052] According to another aspect of the embodiment, the reporting GUI 320 can have a specific arrangement to enhance the user's ability to identify patterns across multiple time periods. For example, the x-axis lines of each of the interfaces 320-A, 320-B, 320-C, 320-D, and 320-E can be aligned with each other so that the specific time increments of each interface are also aligned. In this regard, the user can quickly identify whether her analyte level exceeds the analyte threshold at a specific time of day (e.g., after lunch).

[0053] According to another aspect of the embodiment, the report GUI 320 may include the user's name 322, a label indicating the selected reporting period 324, and a "time CGM activity" statistic 325 to indicate the amount of analyte data available during the selected reporting period 324. According to some embodiments, the selected reporting period 324 may be configured by the user. For example, in some embodiments, the selected reporting period 324 may be configured by a selected start date and a selected end date. In other embodiments, the selected reporting period 324 may be configured as a specific time period (e.g., one week, two weeks, one month, etc.). In addition, in some embodiments, the "time CGM activity" statistic may include the percentage of time during which analyte data was obtained during the selected reporting period 324. In other embodiments, the "time CGM activity" statistic may include the actual amount of time (e.g., "12 days 11 hours 32 minutes"). The report GUI 320 may also include a legend 326 that provides a text description of one or more icons displayed in any one or more of the interfaces 320-A, 320-B, 320-C, 320-D, and / or 320-E.

[0054] According to another aspect of the embodiment, the reporting GUI 320 may also include a device tag 328 to indicate the type of device and / or software used to obtain the reported analyte data. For example, the device tag 328 may instruct the user to use a specific analyte monitoring program on their smartphone in conjunction with a specific brand and / or model of on-body analyte sensor. In some embodiments, the device tag 328 may also indicate whether the data from a drug delivery device (e.g., a connected insulin pen, insulin pump, etc.) is obtained for the reporting GUI 320.

[0055] Next reference Figure 3C , depicts another exemplary embodiment of a GUI 330 for an analyte monitoring system, wherein the GUI 330 depicts a user's analyte level over a predetermined time period in conjunction with a plurality of summary metrics. First, the GUI 330 includes Figure 3A 300. Therefore, detailed descriptions of these similar features will not be repeated here.

[0056] According to one aspect of the embodiment, the plurality of summary metrics of the GUI 330 may include a maximum analyte level 332 and a minimum analyte level 334 over a predetermined time period. Additionally, a maximum analyte level 336 and a minimum analyte level 338 for each of the plurality of time increments may be displayed along the x-axis and adjacent to the graphical portion of the GUI 330. For example, Figure 3C , a pair of maximum analyte level 336 and minimum analyte level 338 metrics are displayed for each hour over a twenty-four hour period. Maximum analyte level 336 and minimum analyte level 337 may be particularly useful because, in many embodiments of the present disclosure, the numerical values ​​associated with a trend line are not always easy to determine by visual inspection.

[0057] Next reference Figure 3D , depicts another exemplary embodiment of a GUI 340 for an analyte monitoring system, wherein the GUI 340 depicts a user's analyte level over a predetermined time period in conjunction with a plurality of summary metrics. First, the GUI 340 includes Figure 3B 330. Therefore, detailed descriptions of these similar features will not be repeated here.

[0058] According to one aspect of the implementation, the GUI 340 may include an icon area for displaying certain events along the x-axis. For example, in some implementations, an alarm icon 342 may be displayed in the icon area to indicate that an alarm condition was detected. Furthermore, the position of the alarm icon 342 along the x-axis may indicate to the user the specific time when the alarm condition was detected. Additionally, according to some implementations, an alarm label 341 may be displayed next to the alarm icon 342 to indicate the type of alarm condition. Figure 3D As seen in FIG. 3 , for example, alarm icon 342 is displayed at 3:00 am, with alarm label 341 indicating that a “low” analyte alarm condition was detected at that time.

[0059] According to some embodiments, other alarm conditions for which an alarm label may be displayed may include a "high" analyte alarm condition, an "imminent low" or "critical low" analyte alarm condition, an "expected high" analyte alarm condition, an "expected low" analyte alarm condition, a "rapidly falling" analyte alarm condition, a "rapidly rising" analyte alarm condition, a "signal loss" condition, and the like.

[0060] According to another aspect of the embodiment, a carbohydrate icon 343 and / or a drug icon 344 may be displayed in the icon area to indicate a meal event or an insulin event, respectively. In addition, according to some embodiments, the specific amount (in grams) and / or type (e.g., quick-acting or long-acting) of carbohydrates injected by the user and the number of units of insulin may also be displayed next to the carbohydrate icon 343 or the drug icon 344. Therefore, the user will be able to intuitively determine at a glance whether certain events (e.g., meals or insulin) and the specific details about these events (e.g., grams of carbohydrates or units of quick-acting insulin) have an impact on the trend line.

[0061] In addition, although the icons are displayed in an icon area separate from the graphical portion of the GUI 340, those skilled in the art will appreciate that in alternative embodiments, the icons can be displayed directly on the graph near the trend line. Similarly, detailed information about alarm conditions, grams of carbohydrates, and / or insulin units can also be displayed directly on the graph near the trend line. In some examples, information corresponding to an event (e.g., a user-initiated analyte check 315 and / or exercise icon 316) can be displayed in the icon area along the x-axis (e.g., rather than on the graphical portion near the trend line).

[0062] Next reference Figure 3E , depicts another exemplary embodiment of a reporting GUI 345 for an analyte monitoring system, wherein the reporting GUI 345 includes a plurality of screens 345-A, 345-B, and 345-C, wherein each screen depicts the user's analyte level over different predetermined time periods in conjunction with a plurality of summary metrics. First, the reporting GUI 345 includes a plurality of summary metrics associated with the user's analyte level over different predetermined time periods. Figure 3B 320. In addition, each of the plurality of interfaces 345-A, 345-B, and 345-C includes features similar to those of the reporting GUI 320. Figure 3D Therefore, the detailed description of these similar features will not be repeated here.

[0063] Next reference Figure 3F , depicts another exemplary embodiment of a report GUI 350 for an analyte monitoring system, wherein the report GUI 350 includes a plurality of screens 350-A, 350-B, and 350-C, wherein each screen depicts the user's analyte level over different predetermined time periods in conjunction with a plurality of summary metrics. First, the report GUI 350 includes a plurality of screens 350-A, 350-B, and 350-C. Figure 3E 345, except that report GUI 350 does not include an alert label. Therefore, a detailed description of these similar features will not be repeated here.

[0064] Next reference Figure 3G , depicts another exemplary embodiment of a GUI 355 for an analyte monitoring system, wherein the GUI 355 depicts a user's analyte level over a predetermined time period in conjunction with a plurality of summary metrics. First, the GUI 355 includes Figure 3C 330. Therefore, detailed descriptions of these similar features will not be repeated here.

[0065] According to one aspect of the embodiment, the GUI 355 may include a maximum analyte level 356 and a minimum analyte level 357 for a predetermined time period. Likewise, a maximum analyte level 359 and a minimum analyte level 358 for each time increment (e.g., per hour) may be displayed along the x-axis and adjacent to the graph portion. Figure 3G As can be seen in , if any one of the minimum analyte level and the maximum analyte level is higher than the target analyte range, the numerical value can be displayed in a first color (e.g., orange). If the user's analyte level is higher than the target analyte range, the first color can correspond to the partial color of the trend line and / or the shaded area. Similarly, if any one of the minimum analyte level and the maximum analyte level is lower than the target analyte range, the numerical value can be displayed in a second color (e.g., red). If the user's analyte level is lower than the target analyte range, the second color can correspond to the partial color of the trend line and / or the shaded area. In contrast, if any one of the minimum analyte level and the maximum analyte level is within the target analyte range, the numerical value can be displayed without any coloring. Alternatively, if the user's analyte level is within the target analyte range, the numerical value can be displayed in a color corresponding to the color of the portion of the trend line. Therefore, GUI 355 attracts the user's attention to those parts of the trend line, as well as the corresponding minimum analyte level numerical value or maximum analyte level numerical value, which are outside the target analyte range to allow the user to determine the root cause.

[0066] Next reference Figure 3H , depicts another exemplary embodiment of a GUI 360 for an analyte monitoring system, wherein the GUI 360 depicts a user's analyte level over a predetermined time period in conjunction with a plurality of summary metrics. First, the GUI 360 includes Figure 3G The features of GUI 355 are similar to those of , except for the color scheme. Specifically, if either the minimum analyte level and the maximum analyte level are above the target analyte range, the numerical value is displayed in a first soft color (e.g., yellow). If the user's analyte level is above the target analyte range, the soft color may correspond to a soft shade of the color of the portion of the trend line and / or shaded area. A detailed description of these similar features will not be repeated here.

[0067] Next reference Fig. 3I , depicts another exemplary embodiment of a reporting GUI 365 for an analyte monitoring system, wherein the reporting GUI 365 includes a plurality of screens 365-A, 365-B, 365-C, and 365-D, wherein each screen depicts the user's analyte level over different predetermined time periods in conjunction with a plurality of summary metrics. First, the reporting GUI 365 includes a plurality of summary metrics associated with the user's analyte level over different predetermined time periods. Figure 3F 350. In addition, each of the plurality of interfaces 365-A, 365-B, 365-C, and 365-D includes features similar to those of the reporting GUI 350. Figure 3H 360. Therefore, a detailed description of these similar features will not be repeated here.

[0068] Next reference Figure 3J , depicts another exemplary embodiment of a GUI 370 for an analyte monitoring system, wherein the GUI 370 depicts a user's analyte level over a predetermined time period in conjunction with a plurality of summary metrics. First, the GUI 370 includes Figure 3G 355. For example, GUI 370 includes a maximum analyte level 372 and a minimum analyte level 374 for each time increment (e.g., per hour) displayed along the x-axis and adjacent to the graph portion. Figure 3J As can be seen in FIG. 1 , if either the minimum analyte level and the maximum analyte level are above the target analyte range, the numerical value can be displayed in a first color (e.g., orange). Similarly, if either the minimum analyte level and the maximum analyte level are below the target analyte range, the numerical value can be displayed in a second color (e.g., red). In contrast, if either the minimum analyte level and the maximum analyte level are within the target analyte range, the numerical value can be displayed without any coloring.

[0069] However, according to some embodiments, GUI 370 may be used with Figure 3G355 has many differences. Specifically, GUI 370 does not include some summary metrics present in several embodiments described previously. For example, GUI 370 does not include the "time in range" metric. In addition, GUI 370 does not include the maximum analyte level or the minimum analyte level throughout the predetermined time period. Similarly, GUI 370 does not include the total amount of food or medicine taken in the predetermined time period. GUI 370 can be configured to not display any medication information and only include dietary information. For example, in some embodiments, GUI 370 can include a carbohydrate icon 376 displayed directly on the graphical portion, and the amount of carbohydrate 378 displayed next to the graphic (e.g., below the graphic). In other examples, GUI 370 can be configured to not display any dietary information and only include medication information.

[0070] Next reference Figure 3K , depicts another exemplary embodiment of a report GUI 380 for an analyte monitoring system, wherein the report GUI 380 includes a plurality of screens 380-A, 380-B, 380-C, and 380-D, wherein each screen depicts the user's analyte level over different predetermined time periods in conjunction with a plurality of summary metrics. First, the report GUI 380 includes Fig. 3I 365. In addition, each of the plurality of interfaces 380-A, 380-B, 380-C, and 380-D includes features similar to those of the reporting GUI 365. Figure 3H 360. Therefore, a detailed description of these similar features will not be repeated here.

[0071] However, according to one aspect of the embodiment, GUI 380 is different from the previous embodiment in that if the interface 380-A, 380-B, 380-C and 380-D are outside the target analyte range, each of them will only display the minimum analyte level 382 or the maximum analyte level 384 of each time increment (e.g., every hour). For example, if the minimum analyte level 382 is lower than the target analyte range, the numerical value can be displayed in a first color (e.g., red). Similarly, if the maximum analyte level 384 is higher than the target analyte range, the numerical value can be displayed in a second color (e.g., yellow). However, in contrast, if the minimum analyte level or the maximum analyte level of a specific time increment is within the target analyte range, the numerical value will not be displayed to the user. In this way, GUI 380 can highlight the numerical value that exceeds the target analyte range, enabling the user to better focus on determining the root cause of such analyte excursion. In other words, if the minimum analyte level and the maximum analyte level are higher or lower than the target analyte range, they can be displayed, but if they are within the target analyte range, they are not displayed.

[0072] Next reference Figure 3L , depicts another exemplary embodiment of a reporting GUI 385 for an analyte monitoring system, wherein the reporting GUI 385 includes a plurality of screens 385-A, 385-B, and 385-C, wherein each screen depicts the user's analyte level over different predetermined time periods in conjunction with a plurality of summary metrics. First, the reporting GUI 385 includes Figure 3F 350. In addition, each of the plurality of interfaces 385-A, 385-B, and 385-C includes features similar to those of the reporting GUI 350. Figure 3C Therefore, the detailed description of these similar features will not be repeated here.

[0073] However, according to one aspect of the embodiment, GUI 385 differs from the previous embodiment in that each of interfaces 385-A, 385-B, and 385-C may also include a graphical representation of the amount of medication taken. For example, interface 385-C depicts a first bar portion 387 whose size is proportional to the amount of rapid-acting insulin taken around 7:00am, in this case "1u". In addition, interface 385-C depicts a second bar portion 388 whose size is proportional to the amount of rapid-acting insulin taken around 11:00am, in this case "3u". Therefore, the second bar portion 388 is larger than the first bar portion 387. In addition, interface 385-C depicts a medication icon 389 labeled "20u" to indicate a dose of long-acting insulin taken around 9:00pm. According to some embodiments, icon 389 is used to reflect different types of insulin (e.g., rapid-acting vs. long-acting) and / or to take into account proportions (i.e., a 20u bar portion would not fit on the chart if scaled based on the first and second bar portions).

[0074] Next reference Figure 4A , depicting an exemplary embodiment of a report setting GUI 405 for an analyte monitoring system. According to one aspect of some embodiments, the display of the minimum analyte level and the maximum analyte level can be enabled and / or disabled by the report setting GUI 405. In some embodiments, for example, the report setting GUI 405 may include an edit button 407, which, when pressed, also displays a check box 409, which allows the user to enable or disable the display of the minimum analyte level and the maximum analyte level. In some embodiments, the check box 409 can be presented via a separate interface (e.g., modal). In other embodiments, the check box 409 can be presented on the report setting GUI 405. In addition, although the check box 409 is shown in the depicted embodiment, it will be understood by those skilled in the art that other GUI objects and / or features, such as radio buttons, sliders, drop-down menus, switches, etc., can be implemented. In some embodiments, the display of the minimum analyte level and the maximum analyte level can be enabled by default. In other embodiments, the display of the minimum analyte level and the maximum analyte level can be disabled by default.

[0075] Next reference Figure 4B , depicts an exemplary embodiment of a report GUI 415 for an analyte monitoring system, wherein via the report setup GUI 405 ( Figure 4A ) enables display of minimum analyte levels and maximum analyte levels. In many aspects, the reporting GUI 415 includes the same Figure 3H ) and Reporting GUI 365( Fig. 3I). Therefore, a detailed description of these similar features will not be repeated here. It should also be noted that the function of enabling and / or disabling the display of minimum analyte levels and maximum analyte levels can be implemented with any GUI and report GUI described herein that include minimum analyte levels and maximum analyte levels.

[0076] Next reference FIG. 4C to FIG. 4E , depicting an exemplary embodiment of a GUI for an analyte monitoring system. According to one aspect of the embodiment, GUI 425, GUI 235, and GUI 445 are exemplary embodiments of a GUI configured to display a user's analyte level over a predetermined time period, and wherein the user's analyte level is displayed via the report setting GUI 405 ( Figure 4A ) disables the display of minimum and maximum analyte levels. For example, Figure 4C is an exemplary embodiment of a GUI 425 depicting a user's analyte level over a predetermined time period, wherein analyte data is transmitted from a sensor control device to a reader device in response to a scan or data request by a reader device (e.g., via NFC). As another example, Figure 4D is an exemplary embodiment of a GUI 435 depicting a user's analyte level over a predetermined time period, wherein the analyte data may be transmitted automatically (e.g., via Bluetooth) and in response to a scan or data request (e.g., via NFC) by a reader device. As yet another example, Figure 4E 4 is an exemplary embodiment of a GUI 445 depicting a user's analyte level over a predetermined time period, wherein the analyte data is automatically transmitted from the sensor control device to the reader device (e.g., via Bluetooth). In addition, although not shown, according to many embodiments, GUI 425, GUI 435, and GUI 445 can also be configured to display graphical portions in conjunction with multiple summary metrics, such as Figure 3A , Figure 3B and portions of graphics shown elsewhere in this disclosure.

[0077] According to another aspect of some embodiments, information associated with a plurality of analytes may be displayed on a GUI or GUI report in a manner similar to previously disclosed embodiments. Figure 5 5 is another exemplary embodiment of a reporting GUI 510 for an analyte monitoring system, wherein the reporting GUI 510 includes a plurality of screens, wherein each screen depicts a user's glucose level over different predetermined time periods in conjunction with a plurality of summary metrics. In many aspects, the GUI 510 includes information related to Fig. 3I The report GUI described in the previous section has similar features to those in the previous section. Therefore, the detailed description of these similar features will not be repeated here.

[0078] According to another aspect of some embodiments, the report GUI 510 may also include information related to a second analyte (e.g., ketones). Specifically, multiple interfaces are provided, each of which depicts the user's glucose level and ketone level over a predetermined time period. In addition, in some embodiments, a summary metric 515 of a second analyte (e.g., ketones) may be displayed, including, for example, multiple high ketone threshold alarms 517, multiple elevated ketone threshold alarms 518, and / or a maximum ketone level 519 over a predetermined time period. Furthermore, in some embodiments, a graphical portion 520 adjacent to a glucose graph portion may depict ketone levels over a predetermined time period such that the graphical portion 520 is aligned along the same x-axis (e.g., time) as the glucose graphical portion. As shown in FIG. Figure 5 As shown in , in some embodiments, the graphical portion 520 may include a trend line 521 that depicts the user's ketone level over a predetermined time period. In other embodiments, discrete data points may be displayed instead of the trend line 521. In addition, the graphical portion 520 may also include numerical values ​​522, 523 that exceed a high ketone threshold or an elevated ketone threshold. Figure 5 As seen in , the numerical values ​​can be displayed with different shades or colors associated with specific thresholds. In some embodiments, the graphical portion 520 can also include an alarm indicator 525 (e.g., text, a mark, an icon, or a symbol) to indicate to the user when a ketone alarm condition is triggered. According to an aspect of some embodiments, the numerical values ​​522, 523 and the alarm indicator 525 can be located on the graphical portion 520 so that they are aligned on the same x-axis (e.g., time) as the trend line 521 and the glucose graphical portion.

[0079] According to another aspect of some embodiments, the report GUI 510 can be configured such that if the level of the second analyte (eg, ketone) is within a predetermined target range for a predetermined period of time, then the trend line is not displayed. Figure 5 , an exemplary embodiment of a second interface including a second summary metric portion 550 and a second graphical portion 555 is shown below the first interface described above. Here, during a second predetermined time period (e.g., "Monday, June 4"), the level of the second analyte is within a predetermined target range. Therefore, the second summary metric 550 can indicate that no alarm was activated during the second predetermined time period. In addition, the second graphical portion 555 does not include a trend line, but can include an indicator (e.g., text, mark, icon, or symbol) that the level of the second analyte is "normal" during the second predetermined time period. In some embodiments, the second graphical portion 555 can be more compact relative to the first graphical portion 520 because less area of ​​the report GUI 510 is required.

[0080] Those skilled in the art will appreciate that any GUI, report interface or part thereof as described herein is only for illustration, and any combination of single element or element depicted and / or described for a particular embodiment or figure can be freely combined with any element or element combination depicted and / or described for any other embodiment.For example, in each of the embodiments described, the display of dietary information (e.g., the amount of carbohydrates) and drug information (e.g., rapid-acting insulin and long-acting insulin) for each time increment can be provided or omitted.In addition, in each of the embodiments described, the display of alarm icons and alarm labels within a predetermined time period can be provided or omitted.In each of the embodiments described, the display of the graphical representation of the drug amount can also be provided or omitted.In each of the embodiments described, the display of the summary measurement of the total amount of dietary information and / or drug information within a predetermined time period can be provided or omitted.In each of the embodiments described, the "time in range" measurement can be provided or omitted.In each of the embodiments described, the coloring (e.g., trend line, threshold line and / or shaded portion) of the graph can be provided or omitted.

[0081] In some embodiments, data indicative of a user's analyte level can be wirelessly transmitted from the sensor control device 102 to the reader device 120, e.g., automatically (i.e., without user intervention). For example, the sensor control device 102 can periodically transmit the analyte data to the reader device (e.g., via Bluetooth or BLE) without requiring the user to manually perform a scan (e.g., via NFC).

[0082] In an analyte monitoring system in which data indicative of a user's analyte level is wirelessly and automatically transmitted from the sensor control device 102 to the reader device 120, the embodiments described herein may be advantageous because numerical values ​​associated with the subject's analyte level at each time increment over a predetermined time period (or a subset thereof) may be periodically displayed, allowing the user (or her HCP) to make more informed treatment decisions. The numerical values ​​associated with each time increment may be further associated with events (such as medications, exercise, and / or meals), thereby providing the user (or her HCP) with a reliable overview of the user's overall glycemic control over the predetermined time period.

[0083] It will also be appreciated by those skilled in the art that any GUI, reporting interface, or portion thereof, as described herein, may be implemented in an analyte monitoring system for monitoring one or more analytes. These analytes may include one or more of glucose, ketones, lactate, alcohol, or any other analyte detectable in a user's bodily fluids. Preferably, the analyte includes glucose. It will also be appreciated by those skilled in the art that, as described herein, a GUI, reporting interface, or portion thereof, may incorporate data received from multiple analyte monitoring systems and associated devices, including incorporating data from devices for performing ex vivo analyte measurements and / or physiological measurements.

[0084] It should be noted that all features, elements, components, functions, and steps described with respect to any embodiment provided herein are intended to be freely combined and replaced with those from any other embodiment. If a feature, element, component, function, or step is described with respect to only one embodiment, it should be understood that the feature, element, component, function, or step can be used with each of the other embodiments described herein unless otherwise expressly stated. Therefore, this paragraph serves as a pre-condition and written support for the introduction of claims at any time that combine the features, elements, components, functions, and steps of different embodiments, or replace those of one embodiment with the features, elements, components, functions, and steps of another embodiment, even if the following description does not expressly state that such a combination or replacement is possible in a particular case. It is expressly acknowledged that the description of every possible combination and replacement is overly cumbersome, especially considering that the permissibility of each such combination and replacement will be readily recognized by a person of ordinary skill in the art.

[0085] Although the embodiments are susceptible to various modifications and alternative forms, specific examples thereof have been shown in the drawings and described in detail herein. However, it should be understood that these embodiments are not limited to the specific forms disclosed, but rather, these embodiments will cover all modifications, equivalents, and alternatives that fall within the spirit of the present disclosure. In addition, any features, functions, steps, or elements of the embodiments may be listed in or added to the claims, as well as negative limitations on the scope of the invention of the claims by defining features, functions, steps, or elements that are not within the scope.

[0086] In summary, an improved graphical user interface for an analyte monitoring system is provided. For example, various embodiments of a GUI are disclosed herein, each GUI comprising: a graphical portion including a trend line indicating a user's analyte level over a predetermined time period; and a plurality of summary metrics including a plurality of minimum analyte levels and a maximum analyte level associated with a plurality of time increments over the predetermined time period. In many embodiments, the plurality of minimum analyte levels and the maximum analyte levels are aligned with an x-axis of the graphical portion.

[0087] The disclosure of this application also includes the following numbered clauses:

[0088] 1. An analyte monitoring system comprising:

[0089] a sensor control device including an analyte sensor coupled to sensor electronics, the sensor control device being configured to be worn on a user's body and to transmit data indicative of the user's analyte level; and

[0090] A reader device comprising:

[0091] monitor;

[0092] wireless communications circuitry configured to receive data indicative of an analyte level of a user;

[0093] One or more processors are coupled to a memory, the memory being configured to store instructions, which when executed by the one or more processors, cause the one or more processors to output a graphical user interface (GUI) to a display, the graphical user interface comprising:

[0094] a graphical portion including a trend line indicating an analyte level of a user over a predetermined time period, wherein the trend line is based on received data indicating the analyte level of the user; and

[0095] a plurality of summary metrics associated with the predetermined time period, wherein the plurality of summary metrics include a plurality of minimum analyte levels and a maximum analyte levels associated with a plurality of time increments within the predetermined time period, and

[0096] Wherein the graph portion includes an x-axis having units of time, and wherein the plurality of minimum analyte levels and the maximum analyte levels are aligned with the x-axis of the graph portion.

[0097] 2. The analyte monitoring system of clause 1, wherein the predetermined time period is one day.

[0098] 3. The analyte monitoring system of clause 1 or 2, wherein the plurality of time increments comprises twenty-four one-hour increments.

[0099] 4. An analyte monitoring system according to any preceding clause, wherein the x-axis comprises a plurality of labels arranged in two-hour increments.

[0100] 5. An analyte monitoring system according to any preceding clause, wherein the graphical portion further comprises a y-axis line comprising units indicating analyte level concentration.

[0101] 6. An analyte monitoring system according to any preceding clause, wherein the graphical portion further comprises a first label for a high analyte threshold and a second label for a low analyte threshold.

[0102] 7. An analyte monitoring system according to any preceding clause, wherein the graphical portion further comprises a first line indicating a high analyte threshold and a second line indicating a low analyte threshold.

[0103] 8. An analyte monitoring system according to any preceding clause, wherein the plurality of minimum analyte levels and maximum analyte levels comprises:

[0104] where the one or more minimum analyte levels are above a high analyte level threshold, the one or more minimum analyte levels depicted in a first color; and

[0105] Where the one or more maximum analyte levels are above the high analyte level threshold, the one or more maximum analyte levels are depicted in a first color.

[0106] 9. The analyte monitoring system of clause 8, wherein the plurality of minimum analyte levels and maximum analyte levels further comprises:

[0107] where the one or more minimum analyte levels are below the low analyte level threshold, the one or more minimum analyte levels depicted in a second color; and

[0108] Where the one or more maximum analyte levels are below the low analyte level threshold, the one or more maximum analyte levels are depicted in a second color.

[0109] 10. The analyte monitoring system of any preceding clause, wherein the plurality of summary metrics further comprises a time-in-range metric.

[0110] 11. The analyte monitoring system of clause 10, wherein the time in range metric is displayed as a percentage.

[0111] 12. An analyte monitoring system according to any preceding clause, wherein the plurality of summary metrics further comprises a total amount of carbohydrates consumed during the predetermined time period.

[0112] 13. An analyte monitoring system according to any preceding clause, wherein the plurality of summary metrics further comprises a total amount of medication taken during the predetermined time period.

[0113] 14. An analyte monitoring system according to any of the preceding clauses, wherein the trend line comprises a first portion of a first color and a second portion of a second color, wherein the first portion indicates an analyte level above a high analyte threshold and wherein the second portion indicates an analyte level between a low analyte threshold and a high analyte threshold.

[0114] 15. The analyte monitoring system of clause 14, wherein the trend line further comprises a third portion of a third color, wherein the third portion indicates an analyte level below a low analyte threshold.

[0115] 16. The analyte monitoring system according to any preceding clause, further comprising an icon area configured to display a plurality of event icons, wherein the plurality of event icons comprises at least one of: an alarm icon, a carbohydrate icon, and a medication icon.

[0116] 17. The analyte monitoring system of clause 16, wherein the alarm icon comprises an alarm label configured to textually describe the alarm condition associated with the alarm icon.

[0117] 18. An analyte monitoring system according to clause 16 or 17, wherein the alarm condition is selected from the group consisting of: a high analyte alarm condition, an imminent low analyte alarm condition, a predicted high analyte alarm condition, a predicted low analyte alarm condition, a rapidly falling analyte alarm condition, a rapidly rising analyte alarm condition, and a signal loss condition.

[0118] 19. An analyte monitoring system according to any one of clauses 16 to 18, wherein the plurality of event icons are configured to be displayed aligned with an x-axis line of the graphical portion.

[0119] 20. An analyte monitoring system according to any preceding clause, wherein the data indicative of the user's analyte level comprises glucose data.

Claims

1. An analyte monitoring system comprising: a sensor control device including an analyte sensor coupled to sensor electronics, the sensor control device being configured to be worn on a user's body and to transmit data indicative of an analyte level of the user; as well as A reader device comprising: monitor; wireless communications circuitry configured to receive said data indicative of an analyte level of said user; One or more processors coupled to a memory, the memory being configured to store instructions, which, when executed by the one or more processors, cause the one or more processors to output a graphical user interface (GUI) to the display, the graphical user interface comprising: a graphical portion including a trend portion indicating the user's analyte level over a predetermined time period, wherein the trend portion is based on received data indicating the user's analyte level; and a plurality of summary metrics associated with the predetermined time period, wherein the plurality of summary metrics includes a minimum analyte level for the predetermined time period and a maximum analyte level for the predetermined time period, and Wherein the graph portion further comprises an x-axis line having units of time, and wherein a plurality of minimum analyte levels for a plurality of time increments and a plurality of maximum analyte levels for the plurality of time increments are aligned with the x-axis line of the graph portion.

2. The analyte monitoring system of claim 1, wherein: The predetermined time period is one day.

3. The analyte monitoring system of claim 1, wherein: The plurality of time increments includes twenty-four one-hour increments.

4. The analyte monitoring system of claim 3, wherein: The x-axis includes a plurality of labels arranged in two-hour increments.

5. The analyte monitoring system of claim 1, wherein: The graphical portion also includes a y-axis including units indicating analyte level concentration.

6. The analyte monitoring system of claim 1, wherein: The graphical portion also includes a first label for a high analyte threshold and a second label for a low analyte threshold.

7. The analyte monitoring system of claim 6, wherein: The graphical portion also includes a first line indicating the high analyte threshold and a second line indicating the low analyte threshold.

8. The analyte monitoring system of claim 6, wherein: The plurality of minimum analyte levels for the plurality of time increments and the plurality of maximum analyte levels for the plurality of time increments include: one or more minimum analyte levels depicted in a first color if the one or more minimum analyte levels are above the high analyte level threshold; and One or more maximum analyte levels are depicted in the first color if the one or more maximum analyte levels are above the high analyte level threshold.

9. The analyte monitoring system of claim 8, wherein: The plurality of minimum analyte levels for the plurality of time increments and the plurality of maximum analyte levels for the plurality of time increments further include: one or more minimum analyte levels depicted in a second color if the one or more minimum analyte levels are below the low analyte level threshold; and The one or more maximum analyte levels are depicted in the second color if the one or more maximum analyte levels are below the low analyte level threshold.

10. The analyte monitoring system of claim 1, wherein: The plurality of summary metrics also includes an in-range time metric.

11. The analyte monitoring system of claim 10, wherein: The time measurement within the range is displayed as a percentage.

12. The analyte monitoring system of claim 1, wherein: The plurality of summary metrics also includes a total amount of carbohydrates consumed during the predetermined time period.

13. The analyte monitoring system of claim 1, wherein: The plurality of summary metrics also includes a total amount of medication taken during the predetermined time period.

14. The analyte monitoring system of claim 6, wherein: The trend portion includes a first portion of a first color and a second portion of a second color, wherein the first portion indicates analyte levels above the high analyte threshold and wherein the second portion indicates analyte levels between the low analyte threshold and the high analyte threshold.

15. The analyte monitoring system of claim 14, wherein: The trend portion also includes a third portion of a third color, wherein the third portion indicates an analyte level below the low analyte threshold.

16. The analyte monitoring system of claim 1, further comprising an icon area configured to display a plurality of event icons, wherein: The plurality of event icons include at least one of: an alarm icon, a carbohydrate icon, and a medication icon.

17. The analyte monitoring system of claim 16, wherein: The alarm icon includes an alarm label configured to textually describe an alarm condition associated with the alarm icon.

18. The analyte monitoring system of claim 16, wherein: The alarm condition is selected from the group consisting of a high analyte alarm condition, an imminent low analyte alarm condition, a predicted high analyte alarm condition, a predicted low analyte alarm condition, a rapidly falling analyte alarm condition, a rapidly rising analyte alarm condition, and a loss of signal condition.

19. The analyte monitoring system of claim 16, wherein: The plurality of event icons are configured to be displayed aligned with the x-axis line of the graphical portion.

20. The analyte monitoring system of claim 1, wherein: The data indicative of the user's analyte level includes glucose data.

21. The analyte monitoring system of claim 1, wherein: The trend portion is a continuous trend line.

22. The analyte monitoring system of claim 1, wherein: The trend portion includes a plurality of discrete data points.

Images